Fagara Bark

Fagara bark (Zanthoxylum zanthoxyloides and related species) contains benzophenanthridine alkaloids (fagaronine, chelerythrine), divanilloylquinic acids, phenylpropanoids, and acid amides that inhibit phospholipase A2, block platelet aggregation, intercalate DNA to inhibit topoisomerases I/II, and exhibit antisickling, antidiabetic, antimalarial, and cytotoxic properties against multi-drug-resistant cancer cells. Ouattara et al. (2009) demonstrated that divanilloylquinic acids isolated from F. zanthoxyloides possess significant in vitro antisickling activity (PMID 19110407), while Goodman et al. (2019) confirmed anti-plasmodial effects against Plasmodium falciparum (PMID 31365939), and Mbaveng et al. (2019) showed the bark extract of F. tessmannii exhibits potent cytotoxicity toward multi-factorial drug-resistant cancer cell lines by circumventing P-glycoprotein efflux (PMID 30703492).

Origin & History

Fagara Bark (Zanthoxylum spp.) is sourced from trees native to the tropical rainforests and savannah zones of West and Central Africa. It is traditionally revered for its stimulating properties, particularly in supporting circulation and alleviating pain.

Historical & Cultural Context

In West African cosmology, Fagara Bark is known as the "tree of fire and flow." It was traditionally used by healers, warriors, and women to awaken energy, protect space, and warm the blood, symbolizing resilience, sacred movement, and spiritual power.

Health Benefits

- **Supports blood circulation**: by promoting vasodilation.
- **Provides pain relief**: through its analgesic compounds.
- **Modulates nervous system**: balance, contributing to stress adaptation.
- **Stimulates digestion, enhancing**: gut motility and enzyme secretion.
- **Contributes to hormonal**: harmony, particularly in women's health.
- **Enhances immune defense**: with its antimicrobial properties.

How It Works

Fagara bark's benzophenanthridine alkaloids—fagaronine and chelerythrine—intercalate into double-stranded DNA and inhibit topoisomerase I and II activity, inducing apoptosis in multi-drug-resistant cancer cells by circumventing P-glycoprotein (ABCB1) efflux pumps, as demonstrated by Mbaveng et al. (PMID 30703492). Divanilloylquinic acids exert antisickling effects by interacting with deoxygenated hemoglobin S (HbS), inhibiting the polymerization cascade that causes erythrocyte sickling (PMID 19110407). The bark's methanol and ethyl acetate fractions inhibit phospholipase A2 (PLA2) and cyclooxygenase pathways, reducing arachidonic acid release and downstream prostaglandin/leukotriene synthesis, which underlies anti-inflammatory and analgesic actions. Phenylpropanoids and acid amides identified in the bark (PMID 1446354) contribute to antimicrobial activity by disrupting microbial membrane integrity, while antioxidant lignans scavenge reactive oxygen species, as confirmed by Chaaib et al. (PMID 12709897).

Scientific Research

Ouattara et al. (2009) isolated divanilloylquinic acids from Fagara zanthoxyloides bark and demonstrated significant antisickling activity in vitro, establishing therapeutic promise for sickle cell disease management (Phytomedicine, PMID 19110407). Amah et al. (2022) showed that the ethyl acetate fraction of F. zanthoxyloides root-bark attenuated alloxan-induced hyperglycemia and associated diabetic complications in Wistar rats, confirming antidiabetic properties (J Ethnopharmacol, PMID 35381308). Mbaveng et al. (2019) reported that crude extract and isolated constituents from F. tessmannii bark exhibited potent cytotoxicity against multi-factorial drug-resistant cancer cells, with mechanisms bypassing P-glycoprotein-mediated efflux (J Ethnopharmacol, PMID 30703492). Goodman et al. (2019) confirmed anti-plasmodial effects of Zanthoxylum zanthoxyloides against Plasmodium species, supporting traditional use of fagara bark in malaria-endemic regions (Planta Med, PMID 31365939).

Clinical Summary

Current evidence is limited to in vitro and animal studies, with no human clinical trials reported. Laboratory studies demonstrate significant PLA2 inhibition and platelet aggregation reduction (p < 0.05) using methanol root-bark extracts. Related Fagara macrophylla species showed antibacterial activity with MIC values of 64 µg/mL against E. coli and Enterobacter aerogenes. Human clinical trials are urgently needed to establish therapeutic efficacy, optimal dosing, and safety profiles in clinical populations.

Nutritional Profile

- Phytochemicals: Alkaloids (fagaramide), Lignans, Flavonoids, Coumarins, Terpenes, Essential oils (limonene, linalool).
- Minerals: Zinc, Manganese, Iron.
- Bioactive actions: Delivers adaptogenic, anti-inflammatory, antimicrobial, and circulatory-enhancing properties.

Preparation & Dosage

- Traditionally chewed, decocted, or powdered into blood tonics, fertility blends, and digestive bitters.
- Used in spiritual cleansing baths and as protective amulets.
- Modern uses include circulatory tonics, pain formulas, stress-relief teas, and women's health supplements.
- Recommended dosage: 1–2 g/day powdered bark or 250–500 mg/day extract.
- Caution: Avoid during pregnancy.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Cardio & Circulation | Mood & Stress
Primary Pairings: - Turmeric (Curcuma longa)
- Ginger (Zingiber officinale)
- Ashwagandha (Withania somnifera)
- Camu Camu (Myrciaria dubia)

Safety & Interactions

Acute toxicity studies on Fagara species bark extracts suggest a relatively wide safety margin at traditional doses, though high-dose methanol extracts have shown hepatotoxicity and nephrotoxicity in rodent models, warranting caution with prolonged use. Because benzophenanthridine alkaloids such as chelerythrine inhibit protein kinase C and interact with DNA-processing enzymes, fagara bark may potentiate the effects of chemotherapeutic agents (e.g., doxorubicin, etoposide) and should be avoided without oncologist supervision. Potential CYP3A4 and CYP2D6 modulation by Zanthoxylum alkaloids has been suggested in the broader Rutaceae literature, raising concern for drug interactions with statins, anticoagulants, and antiretrovirals. Pregnant and breastfeeding women should avoid fagara bark due to uterotonic properties reported in traditional medicine and insufficient human safety data.